Patents Assigned to Advanced Proteone Therapeutics Inc.
  • Site-specific labeling and targeted delivery of proteins for the treatment of cancer
    Patent number: 9545449
    Abstract: The present invention relates to the formation of protein conjugates from proteins chemically modified for linkage to (1) anticancer drug pharmacophores, (2) ligands to biomarkers on cancer cell surfaces, (3) and/or another protein molecule. It provides and specifies new compositions, methods and combinations for tumor, and tumor vasculature targeting and cancer treatment.
    Type: Grant
    Filed: May 13, 2013
    Date of Patent: January 17, 2017
    Assignee: Advanced Proteone Therapeutics Inc.
    Inventor: Alexander Krantz